[1D10-13] Medical RI Production 1

[1D11] Medical RI production using domestic nuclear infrastructures for self-sustenance

(2)Japan market size estimation on Ac225 radiopharmaceuticals

*Yumi Kawata¹, Takeo Morooka¹, Sunao Fujioka¹, Naoyuki Takaki² (1. Japan Medical Isotope K.K., 2. TOKYO CITY UNIVERSITY )

Keywords:Ac-225

As for the clinical application of Ac-225, as of the end of 2021, Phase I clinical trials for malignant melanoma, glioma, and leukemia have been initiated overseas, and preclinical trials are underway for prostate cancer, breast cancer, ovarian cancer, and various neuroendocrine tumors. Assuming that the Ac-225 drug will be developed for prostate cancer, we estimated the future market size in Japan.